Target Trial Emulation: New Method or Rigorous Science?

• Introduce the target trial emulation framework and how it structures secondary data analyses using clearly defined study questions and design principles
• Explore the importance of clarity and transparency in real-world study design
• Discuss what a design-first approach means for industry when using secondary data, including implications for planning and execution of RWE studies

Speakers:

Katrien Wijndaele

Director, Health Outcomes, RWE

Eli Lilly & Co.